109 related articles for article (PubMed ID: 1512503)
1. [A case of meningeal myeloma associated with consciousness disorder].
Banba H; Shimizu T; Nakajima T; Mochizuki T
Nihon Naika Gakkai Zasshi; 1992 May; 81(5):726-7. PubMed ID: 1512503
[No Abstract] [Full Text] [Related]
2. Meningeal myeloma in the absence of systemic disease, and as the initial feature of disease progression.
Somers LJ; Shaw B; Lyn BE; McMillan AM; Mahendra P
Clin Lab Haematol; 1998 Jun; 20(3):189-90. PubMed ID: 9681237
[TBL] [Abstract][Full Text] [Related]
3. [Meningeal infiltration in multiple myeloma. Study of a new case and literature review].
Escorsell A; López-Guillermo A; Blade J; Villamor N; Massanes F; Montserrat E; Rozman C
Rev Clin Esp; 1992 Dec; 191(9):478-80. PubMed ID: 1488536
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy of resistant multiple myeloma with vincristine, adriamycin and dexamethasone (VAD).
Maniatis A; Stamatellou M; Papanastasiou K
Chemioterapia; 1987 Jun; 6(2 Suppl):727-8. PubMed ID: 3509532
[No Abstract] [Full Text] [Related]
5. Thalidomide for the treatment of leptomeningeal multiple myeloma.
Yutaka H; Mariko Y; Shinichiro O; Kunihiko M; Yusuke T; Yasuo I
Eur J Haematol; 2006 Apr; 76(4):358-9. PubMed ID: 16519710
[No Abstract] [Full Text] [Related]
6. [Improved prognosis of generalized AL-amyloidosis in a patient with multiple myeloma treated according to the VAD protocol].
Sarkisova IA; Rameev VV; Kozlovskaia LV; Andreeva NE
Ter Arkh; 2003; 75(8):81-2. PubMed ID: 14520860
[No Abstract] [Full Text] [Related]
7. Intracranial multifocal dural involvement in multiple myeloma: case report and review of the literature.
Méndez CE; Hwang BJ; Destian S; Mazumder A; Jagannath S; Vesole DH
Clin Lymphoma Myeloma Leuk; 2010 Jun; 10(3):220-3. PubMed ID: 20511169
[TBL] [Abstract][Full Text] [Related]
8. [Meningeal plasmacytoma: delayed diagnosis with sequelae].
Buchbender C; Antoch G; Nawatny J
Rofo; 2011 Aug; 183(8):761-2. PubMed ID: 21442568
[No Abstract] [Full Text] [Related]
9. [Results of treatment of patients with advanced multiple myeloma with the vincristine-adriamycin-dexamethasone protocol].
Marisavljević D; Bosković D; Radosević N; Elezović I; Tomin D; Gotić M; Antunović P
Srp Arh Celok Lek; 1996; 124(11-12):292-6. PubMed ID: 9132962
[TBL] [Abstract][Full Text] [Related]
10. Vincristine, adriamycin and high dose steroids in myeloma complicated by renal failure.
Aitchison RG; Reilly IA; Morgan AG; Russell NH
Br J Cancer; 1990 May; 61(5):765-6. PubMed ID: 2337514
[No Abstract] [Full Text] [Related]
11. Neck mass as primary manifestation of multiple myeloma originating in the thyroid cartilage.
Gross M; Eliashar R; Petrova P; Goldfarb A; Sichel JY
Otolaryngol Head Neck Surg; 2002 Mar; 126(3):326-8. PubMed ID: 11956544
[No Abstract] [Full Text] [Related]
12. [Pneumonia caused by Salmonella in a patient with myeloma].
Fernández P; Roldán V; García MC; Gil MT; Rivas C
Sangre (Barc); 1995 Jun; 40(3):234-5. PubMed ID: 7570286
[No Abstract] [Full Text] [Related]
13. Meningeal myelomatosis.
Anwer S; Sternberg A
Blood; 2012 Aug; 120(7):1356. PubMed ID: 23066543
[No Abstract] [Full Text] [Related]
14. [Treatment of multiple myeloma resistant to alkylating agents with dexamethasone, vincristine and adriamycin in continuous infusion].
Monconduit M; Le Loët X; Bernard JF; Menard JF; Grosbois B; Michaux JL; De Gramont A; Laporte JP; Najman A; Jouet JP
Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):477-9. PubMed ID: 3616472
[No Abstract] [Full Text] [Related]
15. [Multiple myeloma of the IgD-lambda type invading CNS].
Kitamura K; Takeuchi J; Kanbe E; Oka H; Saiki M; Aikawa S; Kura Y; Hatta Y; Yamazaki T; Ito T; Sawada U; Horie T
Rinsho Ketsueki; 2004 Oct; 45(10):1124-8. PubMed ID: 15553049
[TBL] [Abstract][Full Text] [Related]
16. [Bence Jones type multiple myeloma showing diffuse infiltration to the dura mater by myeloma cells].
Nomoto N; Saito H; Kashimura M; Aoki S; Shibata A
Rinsho Ketsueki; 1995 Jul; 36(7):694-9. PubMed ID: 7563599
[TBL] [Abstract][Full Text] [Related]
17. Pegylated liposomal doxorubicin, vincristine, and dexamethasone provide significant reduction in toxicity compared with doxorubicin, vincristine, and dexamethasone in patients with newly diagnosed multiple myeloma: a Phase III multicenter randomized trial.
Rifkin RM; Gregory SA; Mohrbacher A; Hussein MA
Cancer; 2006 Feb; 106(4):848-58. PubMed ID: 16404741
[TBL] [Abstract][Full Text] [Related]
18. Combination chemotherapy with vincristine, doxorubicin, dexamethasone for refractory or relapsing multiple myeloma.
Monconduit M; Le Loet X; Bernard JF; Michaux JL
Br J Haematol; 1986 Jul; 63(3):599-601. PubMed ID: 3730288
[No Abstract] [Full Text] [Related]
19. Multiple myeloma--transformation to high-grade malignant lymphoma.
Wahlin A; Roos G; Hörnsten P
Acta Oncol; 1988; 27(4):411-3. PubMed ID: 3203000
[No Abstract] [Full Text] [Related]
20. Melphalan-prednisolone and vincristine-doxorubicin-dexamethasone chemotherapy followed by prednisolone/interferon maintenance therapy for multiple myeloma: Japan Clinical Oncology Group Study, JCOG0112.
Chou T; Tobinai K; Uike N; Asakawa T; Saito I; Fukuda H; Mizoroki F; Ando K; Iida S; Ueda R; Tsukasaki K; Hotta T;
Jpn J Clin Oncol; 2011 Apr; 41(4):586-9. PubMed ID: 21247967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
